Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): Application to the design of related α7 selective ligands

被引:18
作者
Kombo, David C. [1 ]
Mazurov, Anatoly [1 ]
Tallapragada, Kartik [1 ]
Hammond, Philip S. [1 ]
Chewning, Joseph [1 ]
Hauser, Terry A. [1 ]
Vasquez-Valdivieso, Montserrat [2 ]
Yohannes, Daniel [1 ]
Talley, Todd T. [3 ]
Taylor, Palmer [3 ]
Caldwell, William S. [1 ]
机构
[1] Targacept Inc, Mol Design, Winston Salem, NC 27101 USA
[2] Univ Edinburgh, Struct Biochem Grp, Edinburgh EH9 3JR, Midlothian, Scotland
[3] Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
关键词
AChBPs; Nicotinic acetylcholine receptor alpha 7; Docking; Benzylidene-anabaseine analogs; Spirodiazepine and spiroimidazoline quinuclidine series; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; HYDROPHOBIC ENCLOSURE; ACCURATE DOCKING; PARTIAL AGONIST; FULL AGONIST; REVEALS; GLIDE; ALPHA-4-BETA-2; VARENICLINE;
D O I
10.1016/j.ejmech.2011.09.033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
AChBPs isolated from Lymnaea stagnalis (Ls), Aplysia californica (Ac) and Bulinus truncatus (Bt) have been extensively used as structural prototypes to understand the molecular mechanisms that underlie ligand-interactions with nAChRs [1]. Here, we describe docking studies on interactions of benzylidene anabaseine analogs with AChBPs and alpha 7 nAChR. Results reveal that docking of these compounds using Glide software accurately reproduces experimentally-observed binding modes of DMXBA and of its active metabolite, in the binding pocket of Ac. In addition to the well-known nicotinic pharmacophore (positive charge, hydrogen-bond acceptor, and hydrophobic aromatic groups), a hydrogen-bond donor feature contributes to binding of these compounds to Ac. Bt, and the alpha 7 nAChR. This is consistent with benzylidene anabaseine analogs with OH and NH2 functional groups showing the highest binding affinity of these congeners, and the position of the ligand shown in previous X-ray crystallographic studies of ligand-Ac complexes. In the predicted ligand-Ls complex, by contrast, the ligand OH group acts as hydrogen-bond acceptor. We have applied our structural findings to optimizing the design of novel spirodiazepine and spiroimidazoline quinuclidine series. Binding and functional studies revealed that these hydrogen-bond donor containing compounds exhibit improved affinity and selectivity for the alpha 7 nAChR subtype and demonstrate partial agonism. The gain in affinity is also due to conformational restriction, tighter hydrophobic enclosures, and stronger cation-pi interactions. The use of AChBPs structure as a surrogate to predict binding affinity to alpha 7 nAChR has also been investigated. On the whole, we found that molecular docking into Ls binding site generally scores better than when a alpha 7 homology model, Bt or Ac crystal structure is used. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:5625 / 5635
页数:11
相关论文
共 41 条
[1]   Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake α-neurotoxins and nicotinic receptors [J].
Bourne, Y ;
Talley, TT ;
Hansen, SB ;
Taylor, P ;
Marchot, P .
EMBO JOURNAL, 2005, 24 (08) :1512-1522
[2]   Recent developments in the synthesis of nicotinic acetylcholine receptor ligands [J].
Breining, SR .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (06) :609-629
[3]   Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors [J].
Brejc, K ;
van Dijk, WJ ;
Klaassen, RV ;
Schuurmans, M ;
van der Oost, J ;
Smit, AB ;
Sixma, TK .
NATURE, 2001, 411 (6835) :269-276
[4]   Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures [J].
Celie, PHN ;
van Rossum-Fikkert, SE ;
van Dijk, WJ ;
Brejc, K ;
Smit, AB ;
Sixma, TK .
NEURON, 2004, 41 (06) :907-914
[5]   Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors [J].
Celie, PHN ;
Klaassen, RV ;
van Rossum-Fikkert, SE ;
van Elk, R ;
van Nierop, P ;
Smit, AB ;
Sixma, TK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (28) :26457-26466
[6]   Ligand configurational entropy and protein binding [J].
Chang, Chia-en A. ;
Chen, Wei ;
Gilson, Michael K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (05) :1534-1539
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach [J].
Cho, AE ;
Guallar, V ;
Berne, BJ ;
Friesner, R .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (09) :915-931
[9]   Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation [J].
Coe, JW ;
Brooks, PR ;
Vetelino, MG ;
Wirtz, MC ;
Arnold, EP ;
Huang, JH ;
Sands, SB ;
Davis, TI ;
Lebel, LA ;
Fox, CB ;
Shrikhande, A ;
Heym, JH ;
Schaeffer, E ;
Rollema, H ;
Lu, Y ;
Mansbach, RS ;
Chambers, LK ;
Rovetti, CC ;
Schulz, DW ;
Tingley, FD ;
O'Neill, BT .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) :3474-3477
[10]   Alpha7 nicotinic acetylcholine receptor: A link between inflammation and neurodegeneration [J].
Conejero-Goldberg, Concepcion ;
Davies, Peter ;
Ulloa, Luis .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2008, 32 (04) :693-706